Search Results - "Koning, J. P."

Refine Results
  1. 1

    Pancreatic β-Cell Identity Change through the Lens of Single-Cell Omics Research by Leenders, Floris, de Koning, Eelco J P, Carlotti, Françoise

    “…The main hallmark in the development of both type 1 and type 2 diabetes is a decline in functional β-cell mass. This decline is predominantly attributed to…”
    Get full text
    Journal Article
  2. 2

    Clinical use of donation after circulatory death pancreas for islet transplantation by Doppenberg, Jason B., Nijhoff, Michiel F., Engelse, Marten A., Koning, Eelco J. P.

    Published in American journal of transplantation (01-09-2021)
    “…Due to a shortage of donation after brain death (DBD) organs, donation after circulatory death (DCD) is increasingly performed. In the field of islet…”
    Get full text
    Journal Article
  3. 3

    Fasting parameters for estimation of stimulated β cell function in islet transplant recipients with or without basal insulin treatment by Uitbeijerse, Bas S., Nijhoff, Michiel F., Sont, Jacob K., Koning, Eelco J. P.

    Published in American journal of transplantation (01-01-2021)
    “…In order to assess β cell secretory capacity after islet transplantation, standardized mixed meal stimulation tests are often used. But these tests are…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Organoids from the Human Fetal and Adult Pancreas by Balak, Jeetindra R. A., Juksar, Juri, Carlotti, Françoise, Lo Nigro, Antonio, de Koning, Eelco J. P.

    Published in Current diabetes reports (01-12-2019)
    “…Purpose of Review Novel 3D organoid culture techniques have enabled long-term expansion of pancreatic tissue. This review comprehensively summarizes and…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Pancreatic islet macroencapsulation using microwell porous membranes by Skrzypek, Katarzyna, Groot Nibbelink, Milou, van Lente, Jéré, Buitinga, Mijke, Engelse, Marten A., de Koning, Eelco J. P., Karperien, Marcel, van Apeldoorn, Aart, Stamatialis, Dimitrios

    Published in Scientific reports (23-08-2017)
    “…Allogeneic islet transplantation into the liver in combination with immune suppressive drug therapy is widely regarded as a potential cure for type 1 diabetes…”
    Get full text
    Journal Article
  9. 9

    DNA Methylation Landscapes of Human Fetal Development by Slieker, Roderick C, Roost, Matthias S, van Iperen, Liesbeth, Suchiman, H Eka D, Tobi, Elmar W, Carlotti, Françoise, de Koning, Eelco J P, Slagboom, P Eline, Heijmans, Bastiaan T, Chuva de Sousa Lopes, Susana M

    Published in PLoS genetics (01-10-2015)
    “…Remodelling the methylome is a hallmark of mammalian development and cell differentiation. However, current knowledge of DNA methylation dynamics in human…”
    Get full text
    Journal Article
  10. 10

    Generation of L Cells in Mouse and Human Small Intestine Organoids by PETERSEN, Natalia, REIMANN, Frank, BARTFELD, Sina, FARIN, Henner F, RINGNALDA, Femke C, VRIES, Robert G. J, VAN DEN BRINK, Stieneke, CLEVERS, Hans, GRIBBLE, Fiona M, DE KONING, Eelco J. P

    Published in Diabetes (New York, N.Y.) (01-02-2014)
    “…Upon a nutrient challenge, L cells produce glucagon-like peptide 1 (GLP-1), a powerful stimulant of insulin release. Strategies to augment endogenous GLP-1…”
    Get full text
    Journal Article
  11. 11

    long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation by Cnop, M, Hughes, S. J, Igoillo-Esteve, M, Hoppa, M. B, Sayyed, F, van de Laar, L, Gunter, J. H, de Koning, E. J. P, Walls, G. V, Gray, D. W. G, Johnson, P. R. V, Hansen, B. C, Morris, J. F, Pipeleers-Marichal, M, Cnop, I, Clark, A

    Published in Diabetologia (01-02-2010)
    “…Aims/hypothesis Defects in pancreatic beta cell turnover are implicated in the pathogenesis of type 2 diabetes by genetic markers for diabetes. Decreased beta…”
    Get full text
    Journal Article
  12. 12

    Association between person and disease related factors and the planned diabetes care in people who receive person-centered type 2 diabetes care: An implementation study by van Vugt, Heidi A, de Koning, Eelco J P, Rutten, Guy E H M

    Published in PloS one (24-07-2019)
    “…To assess the planned diabetes care for the coming year and its associated factors in patients with Type 2 diabetes who have a person-centered annual…”
    Get full text
    Journal Article
  13. 13

    Motor Disturbance in ASD: A Pilot Study Showing Hypokinetic Behavior? by Mostert-Kerckhoffs, M. A. L., Willems, A. E., Tenback, D. E., Koning, J. P., Van Harten, P., Staal, W. G.

    “…Data supporting theoretical models linking autism spectrum disorders (ASD) to motor disturbance are inconclusive. In the present study, children and…”
    Get full text
    Journal Article
  14. 14

    A High Cell‐Bearing Capacity Multibore Hollow Fiber Device for Macroencapsulation of Islets of Langerhans by Skrzypek, Katarzyna, Groot Nibbelink, Milou, Liefers‐Visser, Jolanda, Smink, Alexandra M., Stoimenou, Eleftheria, Engelse, Marten A., Koning, Eelco J. P., Karperien, Marcel, Vos, Paul, Apeldoorn, Aart, Stamatialis, Dimitrios

    Published in Macromolecular bioscience (01-08-2020)
    “…Macroencapsulation of islets of Langerhans is a promising strategy for transplantation of insulin‐producing cells in the absence of immunosuppression to treat…”
    Get full text
    Journal Article
  15. 15

    Advances in β-cell replacement therapy for the treatment of type 1 diabetes by Vantyghem, Marie-Christine, de Koning, Eelco J P, Pattou, François, Rickels, Michael R

    Published in The Lancet (British edition) (05-10-2019)
    “…The main goal of treatment for type 1 diabetes is to control glycaemia with insulin therapy to reduce disease complications. For some patients, technological…”
    Get full text
    Journal Article
  16. 16

    COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course by Landstra, Cyril P, de Koning, Eelco J P

    Published in Frontiers in endocrinology (Lausanne) (17-06-2021)
    “…The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most…”
    Get full text
    Journal Article
  17. 17

    Factors that influence the intended intensity of diabetes care in a person‐centred setting by Vugt, H. A., Heijmans, M. J. W. M., Koning, E. J. P., Rutten, G. E. H. M.

    Published in Diabetic medicine (01-07-2020)
    “…Aims To assess the intended intensity of Type 2 diabetes care and the factors associated with that intensity of care after the annual monitoring visit in which…”
    Get full text
    Journal Article
  18. 18

    The adipocytokine Nampt and its product NMN have no effect on beta-cell survival but potentiate glucose stimulated insulin secretion by Spinnler, Robert, Gorski, Theresa, Stolz, Katharina, Schuster, Susanne, Garten, Antje, Beck-Sickinger, Annette G, Engelse, Marten A, de Koning, Eelco J P, Körner, Antje, Kiess, Wieland, Maedler, Kathrin

    Published in PloS one (16-01-2013)
    “…Obesity is associated with a dysregulation of beta-cell and adipocyte function. The molecular interactions between adipose tissue and beta-cells are not yet…”
    Get full text
    Journal Article
  19. 19

    Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice by Ellenbroek, J. H., Töns, H. A. M., Westerouen van Meeteren, M. J. A., de Graaf, N., Hanegraaf, M. A., Rabelink, T. J., Carlotti, F., de Koning, E. J. P.

    Published in Diabetologia (01-09-2013)
    “…Aims/hypothesis Incretin-based therapies improve glycaemic control in patients with type 2 diabetes. In animal models of diabetes, glucagon-like peptide-1…”
    Get full text
    Journal Article
  20. 20